Bienvenue sur HématoStat.net. Nous sommes le : 22, November 2024
Réf :HematoStat.net ; 1 (12) : V35
Thomas Heinickeand al. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials. Annals of Hematology volume 100, pages 2387–2398 (2021). Doi : 10.1007/s00277-021-04565-1
View all posts
Save my name, email, and website in this browser for the next time I comment.
Δ